Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi-Chang Liu

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Biomedicines|March 29, 2023
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck CancerTsung-Jang Yeh, Chi-Wen Luo, Jeng-Shiun Du, et al.
The Oncologist|December 20, 2019
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine CarcinomasMing-Huang Chen, Wen-Chi Chou, Chin-Fu Hsiao, et al.
Biomedicines|December 23, 2023
The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer CohortTsung-Jang Yeh, Hui-Ching Wang, Shih-Feng Cho, et al.
Annals of Nuclear Medicine|May 20, 2026
Baseline FDG PET/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphomaYu-Chieh Lin, Chin-Chuan Chang, Tsung-Jang Yeh, et al.
Journal of Personalized Medicine|February 25, 2022
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern TaiwanJeng-Shiun Du, Yi-Chun Kuo, Hon-Yi Shi, et al.
International Journal of Molecular Sciences|November 14, 2023
Heterogeneity of Phase II Enzyme Ligands on Controlling the Progression of Human Gastric Cancer Organoids as Stem Cell Therapy ModelDeng-Chyang Wu, Chia-Chen Ku, Jia-Bin Pan, et al.
Oncology Letters|November 8, 2024
Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphomaChin-Mu Hsu, Shih-Yu Kao, Chia-Hung Yen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 29, 2025
Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)Wei-Han Huang, Hsin-An Hou, Wen-Chien Chou, et al.
Biomedicines|July 27, 2022
Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and AutophagyChin-Mu Hsu, Chia-Hung Yen, Shu-Chen Wang, et al.
Journal of Personalized Medicine|September 28, 2021
Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C InfectionYu-Fen Tsai, Yi-Chang Liu, Ching-I Yang, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Biomedicines|March 29, 2023
Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck CancerTsung-Jang Yeh, Chi-Wen Luo, Jeng-Shiun Du, et al.
The Oncologist|December 20, 2019
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine CarcinomasMing-Huang Chen, Wen-Chi Chou, Chin-Fu Hsiao, et al.
Biomedicines|December 23, 2023
The Prognosis Performance of a Neutrophil- and Lymphocyte-Associated Gene Mutation Score in a Head and Neck Cancer CohortTsung-Jang Yeh, Hui-Ching Wang, Shih-Feng Cho, et al.
Annals of Nuclear Medicine|May 20, 2026
Baseline FDG PET/CT SUVmax predicts POD24 and progression-free survival in newly diagnosed follicular lymphomaYu-Chieh Lin, Chin-Chuan Chang, Tsung-Jang Yeh, et al.
Journal of Personalized Medicine|February 25, 2022
The Cost-Effectiveness Analysis of Transplant-Ineligible Myeloma Patients with Bortezomib plus Thalidomide plus Dexamethasone (VTD) or Bortezomib plus Melphalan plus Prednisolone (VMP) Treatment in Southern TaiwanJeng-Shiun Du, Yi-Chun Kuo, Hon-Yi Shi, et al.
International Journal of Molecular Sciences|November 14, 2023
Heterogeneity of Phase II Enzyme Ligands on Controlling the Progression of Human Gastric Cancer Organoids as Stem Cell Therapy ModelDeng-Chyang Wu, Chia-Chen Ku, Jia-Bin Pan, et al.
Oncology Letters|November 8, 2024
Biomarker potential of nuclear Nrf2 activation in the ABC subtype of diffuse large B‑cell lymphomaChin-Mu Hsu, Shih-Yu Kao, Chia-Hung Yen, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|October 29, 2025
Consensus of the Hematology Society of Taiwan on the management of paroxysmal nocturnal hemoglobinuria (PNH)Wei-Han Huang, Hsin-An Hou, Wen-Chien Chou, et al.
Biomedicines|July 27, 2022
Emodin Ameliorates the Efficacy of Carfilzomib in Multiple Myeloma Cells via Apoptosis and AutophagyChin-Mu Hsu, Chia-Hung Yen, Shu-Chen Wang, et al.
Journal of Personalized Medicine|September 28, 2021
Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C InfectionYu-Fen Tsai, Yi-Chang Liu, Ching-I Yang, et al.
Pageof 13